跳至主要内容
临床试验/NCT05724407
NCT05724407尚未招募不适用

Evaluation of the Use of a Diagnostic Assistance Tool of Prognostic and Predictive Marker Scoring System in Breast Cancer

Assistance Publique - Hôpitaux de Paris0 个研究点目标入组 220 人开始时间: 2023年3月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
220
主要终点
Diagnostic performances

研究概览

简要总结

The main objective of this study is to evaluate and compare the diagnostic performance of a diagnostic assistance tool for analysis of 5 prognostic and predictive markers of breast cancer (HER2, Ki67 Index, Mitoses, Estrogen Hormone Receptor, Hormone Progesteron receptors hormone of Progesteronereceptor) integrating an automatic analysis algorithm compared to a reference (gold standard defined as the rereading by at least two different anatomopathologists according to the standard method of care) in order to show the non-inferiority of the automatic analysis algorithm compared to this gold standard.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients over 18 years of age
  • Understanding French
  • With symptoms of breast cancer that required a biopsy (microbiopsy or macrobiopsy or surgical biopsy) and pathological examination diagnosing breast cancer
  • First diagnosis of invasive breast cancercarcinoma
  • Affiliated to a social security system
  • Agreeing to participate in the study

排除标准

  • Refusal to participate in the study
  • Not affiliated to the social security system
  • Minor or under legal protection
  • Patient with a history of breast cancer
  • Patient previously treated for breast cancer
  • Patient who has relapsed from breast cancer treatment
  • Non ductal or non lobular invasive breast cancer carcinoma

结局指标

主要结局

Diagnostic performances

时间窗: at inclusion

The diagnostic performance of the automatic marker scoring support tool will be assessed based on the pathologists' gold standard using sensitivity and specificity

次要结局

  • Duration of procedure(at inclusion)
  • Cognitive savings(at inclusion)
  • Diagnostic performances(at inclusion)
  • Organizational constraints(at inclusion)
  • inter-rater agreement(at inclusion)
  • General comfort of use(at inclusion)

研究者

申办方类型
Other
责任方
Sponsor

相似试验